Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred Tax AssetsCurrent LeasesGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Elbit Systems (ESLT) Cash & Equivalents (2016 - 2025)

Historic Cash & Equivalents for Elbit Systems (ESLT) over the last 17 years, with Q3 2025 value amounting to $142.6 million.

  • Elbit Systems' Cash & Equivalents rose 1962.6% to $142.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $142.6 million, marking a year-over-year increase of 1962.6%. This contributed to the annual value of $265.4 million for FY2024, which is 3440.33% up from last year.
  • Latest data reveals that Elbit Systems reported Cash & Equivalents of $142.6 million as of Q3 2025, which was up 1962.6% from $109.1 million recorded in Q2 2025.
  • In the past 5 years, Elbit Systems' Cash & Equivalents ranged from a high of $278.8 million in Q1 2021 and a low of $108.3 million during Q1 2024
  • In the last 5 years, Elbit Systems' Cash & Equivalents had a median value of $211.1 million in 2022 and averaged $201.7 million.
  • Its Cash & Equivalents has fluctuated over the past 5 years, first crashed by 5926.12% in 2021, then soared by 3440.33% in 2024.
  • Elbit Systems' Cash & Equivalents (Quarter) stood at $259.0 million in 2021, then decreased by 18.49% to $211.1 million in 2022, then decreased by 6.48% to $197.4 million in 2023, then skyrocketed by 34.4% to $265.4 million in 2024, then plummeted by 46.26% to $142.6 million in 2025.
  • Its Cash & Equivalents was $142.6 million in Q3 2025, compared to $109.1 million in Q2 2025 and $113.7 million in Q1 2025.